11.07
Fibrogen Inc Aktie (FGEN) Neueste Nachrichten
Live market analysis of FibroGen Inc.Buy Signal & Expert Approved Momentum Trade Ideas - newser.com
Real time scanner hits for FibroGen Inc. explained2025 Market Overview & Capital Efficiency Focused Strategies - newser.com
Reversal indicators forming on FibroGen Inc. stockInflation Watch & Fast Exit and Entry Strategy Plans - newser.com
Will FibroGen Inc. (1FG0) stock see valuation expansionJuly 2025 Setups & Verified Momentum Stock Watchlist - newser.com
How FibroGen Inc. (1FG0) stock reacts to monetary easing2025 Valuation Update & AI Powered Market Trend Analysis - newser.com
Published on: 2025-10-03 05:46:29 - newser.com
What analysts say about FibroGen Inc stockMid Cap Growth Trends & Maximize ROI With Proven Growth Stocks - earlytimes.in
FibroGen Inc Stock Analysis and ForecastEquity Performance Review & High Return Portfolio Growth - earlytimes.in
What drives FibroGen Inc stock priceMonthly Performance Summary & Reap the Rewards of Patience + Planning - earlytimes.in
What analysts say about FibroGen Inc 1FG0 stockBollinger Bands Signals & Exceptional Capital Growth - earlytimes.in
FibroGen stock advances as H.C. Wainwright reiterates Buy rating on FG-3246 progress - Investing.com Nigeria
FibroGen stock advances as H.C. Wainwright reiterates Buy rating on FG-3246 progress By Investing.com - Investing.com South Africa
William Blair Remains a Hold on FibroGen (FGEN) - The Globe and Mail
H.C. Wainwright Maintains FibroGen(FGEN.US) With Buy Rating, Maintains Target Price $43 - 富途牛牛
FibroGen initiates phase 2 trial of FG-3246 for prostate cancer By Investing.com - Investing.com South Africa
FibroGen initiates phase 2 trial of FG-3246 for prostate cancer - Investing.com India
FGEN: HC Wainwright & Co. Reiterates 'Buy' Rating with $43 Targe - GuruFocus
FibroGen (FGEN) Launches Phase 2 Trial for Antibody-Drug Conjuga - GuruFocus
FibroGen Initiates Phase 2 Monotherapy Trial of FG-3246, a First-in-Class CD46 Targeting ADC, in Metastatic Castration-Resistant Prostate Cancer - The Manila Times
FibroGen Initiates Phase 2 Trial for FG-3246 in Metastatic Castration-Resistant Prostate Cancer, Evaluating Companion PET Imaging Agent FG-3180 - Quiver Quantitative
FibroGen Initiates Phase 2 Monotherapy Trial of FG-3246, a - GlobeNewswire
First-in-Class CD46 Targeting ADC: FibroGen's FG-3246 Enters Phase 2 Trial for Advanced Prostate Cancer - Stock Titan
FibroGen Stock Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo
Treasury Yields: Is FibroGen Inc stock a buy or sell2025 Trade Ideas & Reliable Momentum Entry Alerts - خودرو بانک
Market Catalysts: Is FibroGen Inc vulnerable to short sellersVolume Spike & Free Safe Entry Trade Signal Reports - خودرو بانک
Fed Watch: Why is FibroGen Inc stock going upJuly 2025 Price Swings & Low Drawdown Trading Strategies - khodrobank.com
Aug Volume: Will FibroGen Inc stock benefit from M A2025 Historical Comparison & Capital Protection Trade Alerts - خودرو بانک
What moving averages say about FibroGen Inc.Options Play & High Accuracy Trade Signal Alerts - newser.com
What is FibroGen Incs revenue forecast2025 Trading Volume Trends & Weekly Watchlist of Top Performers - khodrobank.com
Volatility Watch: Can FibroGen Inc sustain its profitabilityWall Street Watch & Smart Allocation Stock Tips - khodrobank.com
Meme Stocks: Is FibroGen Inc stock a value trapBull Run & Breakout Confirmation Alerts - خودرو بانک
Wall Street Zen Upgrades FibroGen (NASDAQ:FGEN) to "Hold" - MarketBeat
Growth Value: Will FibroGen Inc benefit from rising consumer demandQuarterly Trade Review & Consistent Income Trade Recommendations - خودرو بانک
FibroGen appoints David DeLucia CFO - MSN
Aug Selloffs: Is FibroGen Inc. affected by consumer sentimentGap Up & Real-Time Volume Triggers - khodrobank.com
FibroGen Sells Subsidiary to AstraZeneca for $220M - MSN
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):